| 000 | 01903 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517181950.0 | ||
| 264 | 0 | _c20180813 | |
| 008 | 201808s 0 0 eng d | ||
| 022 | _a1437-7780 | ||
| 024 | 7 |
_a10.1016/j.jiac.2017.09.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIgari, Hidetoshi | |
| 245 | 0 | 0 |
_aLymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis. _h[electronic resource] |
| 260 |
_bJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy _cFeb 2018 |
||
| 300 |
_a110-116 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntigens, Bacterial _ximmunology |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xcomplications |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aInterferon-gamma Release Tests |
| 650 | 0 | 4 |
_aLatent Tuberculosis _xcomplications |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocyte Subsets _ximmunology |
| 700 | 1 | _aIshikawa, Satoru | |
| 700 | 1 | _aNakazawa, Takuya | |
| 700 | 1 | _aOya, Yoshihiro | |
| 700 | 1 | _aFutami, Hidekazu | |
| 700 | 1 | _aTsuyuzaki, Mizue | |
| 700 | 1 | _aSuzuki, Kiminori | |
| 700 | 1 | _aMatsumura, Ryutaro | |
| 773 | 0 |
_tJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy _gvol. 24 _gno. 2 _gp. 110-116 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jiac.2017.09.012 _zAvailable from publisher's website |
| 999 |
_c27706803 _d27706803 |
||